AVP and dentinogenesis imperfecta: Administering supraphysiologic levels of desmopressin to our patient may have increased the effects of desmopressin on the kidney to a clinically significant degree since most patients with non-hereditary nephrogenic DI have partial rather than complete resistance to ADH [6, 7, 8].